Disease Progression: Clinical Trials

19 trials for Disease Progression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 6 unknown, 2 recruiting, 2 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 9, Unknown 6, Recruiting 2, Terminated 2

Follow Disease Progression: new trials by email Literature Review of Disease Progression trials Research Report on Disease Progression

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC
Oral Paclitaxel Solution, PD-1/PD-L1 inhibitor, Stereotactic Body Radiotherapy (SBRT) - NSCLC (Non-small Cell Lung Cancer)
Phase 4RecruitingShanghai Pulmonary Hospital, Shanghai, China782026-06-252026-08-10
The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
Propofol, Sevoflurane - Lung Cancer, Progression, Disease
Phase 4RecruitingKaohsiung Medical University Chung-Ho Memorial Hospital3002022-12-272023-05-30
Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19
0.5% Povidone Iodine, 0.12% Chlorhexidine Gluconate Mouth Rinse, 1% Hydrogen Peroxide - COVID-19
Phase 4UnknownOhio State University602020-10-012020-10-27
FREEDOM COVID-19 Anticoagulation Strategy
Enoxaparin, Apixaban - COVID-19, SARS-CoV-2
Phase 4CompletedValentin Fuster34602020-09-082023-03-16
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis
pirfenidone and nintedanib, pirfenidone or nintedanib - Progressive Idiopathic Pulmonary Fibrosis
Phase 4CompletedHospices Civils de Lyon2792020-06-112026-02-09
The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes
Metformin Hydrochloride, lifestyle modification - Chronic Heart Failure, Coronary Artery Disease
Phase 4CompletedNational Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov972018-01-012020-09-16
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Pralatrexate - Peripheral T Cell Lymphoma, Progression, Disease
Phase 4UnknownTaiwan Mundipharma Pharmaceuticals Ltd.222016-08-302017-05-12
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Transurethral Resection, Tamsulosin - Bladder Cancer
Phase 4UnknownDiskapi Teaching and Research Hospital402015-02-012015-05-14
Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease
exercise aerobic - Cardiovascular Disease, Chronic Kidney Disease
Phase 4UnknownFederal University of Pelotas2002011-09-012012-03-05
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
Omega-3 Fatty Acid-Based Parenteral Nutrition, Structolipid - Liver Cancer, Cirrhosis
Phase 4CompletedHuazhong University of Science and Technology3202010-03-012018-08-22
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
IV Iron, Ferrous Sulfate - Chronic Kidney Disease, Iron-deficiency Anemia
Phase 4TerminatedIndiana University1362008-08-012016-07-21
Topical Cyclosporine and Disease Progression
Restasis, Endura - Disease Progression, Disease Severity
Phase 4CompletedInnovative Medical802007-12-012008-09-25
The Long-term Evaluation of Glucosamine Sulphate Study
Glucosamine sulphate and chondroitin, Glucosamine sulphate, Chondroitin sulphate - Osteoarthritis, Knee
Phase 4UnknownUniversity of Sydney6002007-10-012010-06-30
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Intravesical BCG instillation - Bladder Cancer, Disease Progression
Phase 4CompletedAnkara Training and Research Hospital4002007-01-012017-06-05
Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.
Fluvastatin - Aortic Valve Stenosis
Phase 4TerminatedAORTICA Group1642006-10-012019-06-07
Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)
Pantoprazole - Gastroesophageal Reflux Disease
Phase 4CompletedTakeda6392006-06-012012-05-07
Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis
Herkulink renal artery Stent, best medical therapy - Renal Artery Stenosis
Phase 4UnknownMedical University of Vienna1202004-02-012011-07-26
RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
Famciclovir - Recurrent Genital Herpes (RGH)
Phase 4CompletedNovartis2003-06-012012-04-27
When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine - HIV Infections, AIDS-Related Opportunistic Infections
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2832003-03-012014-10-15

Narrower conditions

Pathologic Complete Response (5)  ·  COVID-19 (2)  ·  Recurrence (2)  ·  Renal Insufficiency, Chronic (2)  ·  Urinary Bladder Neoplasms (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Anemia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Aortic Valve Stenosis (1)  ·  Atherosclerosis (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Fibrosis (1)

Broader conditions

Disease Attributes (19)  ·  Pathologic Processes (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Urogenital Diseases (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Male Urogenital Diseases (6)  ·  Neoplasms (6)  ·  Lung Diseases (5)  ·  Neoplasms by Site (5)  ·  Respiratory Tract Diseases (5)  ·  Urologic Diseases (5)  ·  Infections (4)  ·  Virus Diseases (4)

Interventions

10-propargyl-10-deazaaminopterin (1)  ·  Anesthesia, Inhalation (1)  ·  Chondroitin (1)  ·  Clinical Trials as Topic (1)  ·  Cyclosporins (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Enoxaparin (1)  ·  Exercise (1)  ·  Famciclovir (1)  ·  Ferric Oxide, Saccharated (1)  ·  Fluoridation (1)  ·  Fluvastatin (1)  ·  Glucosamine (1)  ·  Hydrogen Peroxide (1)  ·  Immune Checkpoint Inhibitors (1)

Sponsors

AORTICA Group (1)  ·  Ankara Training and Research Hospital (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Federal University of Pelotas (1)  ·  Hospices Civils de Lyon (1)  ·  Huazhong University of Science and Technology (1)  ·  Indiana University (1)  ·  Innovative Medical (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Medical University of Vienna (1)  ·  National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Novartis (1)  ·  Ohio State University (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

United States (6)  ·  Brazil (3)  ·  China (2)  ·  South Africa (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Austria (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Kyrgyzstan (1)  ·  Mexico (1)  ·  Poland (1)  ·  Puerto Rico (1)

Top investigators

Akbay Sarybaev (1)  ·  Andrew R. Zolopa, MD (1)  ·  Anu Lala, MD (1)  ·  Bor-Sheng Ko, PhD (1)  ·  Candido Martin-Luengo, MD, PhD (1)  ·  Charles Bridges-Webb, MB, BS (1)  ·  David L Hall, DDS (1)  ·  John Edmonds, MB,BS (1)  ·  Lynette March, PhD, MB, BS (1)  ·  Mark Woodward, PhD, MSc (1)  ·  Marlene Fransen, PhD, MPH (1)  ·  Nihat Karakoyunlu, MD (1)  ·  Pedro Hallal, phd (1)  ·  Pedro L Sanchez, MD, PhD (1)

Results publications

PMID 18621575, PMID 19440326, PMID 20617176, PMID 21126955, PMID 23170127, PMID 23647688, PMID 23759377, PMID 23982601, PMID 24083350, PMID 24395557, PMID 27614675, PMID 29615792, PMID 33096027, PMID 34086039, PMID 34088340, PMID 34561086, PMID 35241226, PMID 36889611, PMID 37478883, PMID 38512301, PMID 38610980, PMID 39305910, PMID 39614293

NIH funding

2019 (1), U01DK071633 (1)